Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Gilead's wide-open future, biotech's long winter, and Sanofi's ongoing makeover
Fierce editors discuss the future of Gilead Sciences, biotech's continued slump on Wall Street, and the latest move in Sanofi's efforts to right the ship.
Related Episodes
Continue listening to more episodes from FierceBiotech Radio.
